Skip to main content
Signal8

TCG Crossover Management, LLC

TCG Crossover Management, LLC is an Investment Adviser institutional filer with the SEC under CIK 1839948, reporting 54 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in TCG Crossover Management, LLC's most recent 13F filing, ranked by reported market value.

  1. ABIVAX SA AMERICAN DEPOSITARY SHARES (ABVX)
  2. TANGO THERAPEUTICS INC (TNGX)
  3. CG ONCOLOGY INC (CGON)
  4. COGENT BIOSCIENCES INC (COGT)
  5. IMMUNOVANT INC (IMVT)
  6. SPYRE THERAPEUTICS INC (SYRE)
  7. DIANTHUS THERAPEUTICS INC (DNTH)
  8. MIRUM PHARMACEUTICALS INC (MIRM)
  9. ZAI LAB LTD-ADR (ZLAB)
  10. AMYLYX PHARMACEUTICALS INC (AMLX)
/